Wright State University

CORE Scholar
Internal Medicine Faculty Publications

Internal Medicine

11-2017

Predictors of In Hospital Mortality In Acute Pancreatitis
David E. Mossad
Wright State University, david.mossad@wright.edu

Brian V. Dinh
Wright State University, dinh.6@wright.edu

Ronald J. Markert
Wright State University - Main Campus, ronald.markert@wright.edu

Mustafa N. Musleh
Wright State University, mustafa.musleh@wright.edu

Sangeeta Agrawal
Wright State University, sangeeta.agrawal@wright.edu

Follow this and additional works at: https://corescholar.libraries.wright.edu/internal_medicine
Part of the Internal Medicine Commons

Repository Citation
Mossad, D. E., Dinh, B. V., Markert, R. J., Musleh, M. N., & Agrawal, S. (2017). Predictors of In Hospital
Mortality In Acute Pancreatitis. Journal Pancreas, 18 (6), 465-469.
https://corescholar.libraries.wright.edu/internal_medicine/192

This Article is brought to you for free and open access by the Internal Medicine at CORE Scholar. It has been
accepted for inclusion in Internal Medicine Faculty Publications by an authorized administrator of CORE Scholar.
For more information, please contact library-corescholar@wright.edu.

JOP. J Pancreas (Online) 2017 Nov 30; 18(6):465-469.

ORIGINAL ARTICLE

Predictors of In-Hospital Mortality in Acute Pancreatitis
David Mossad, Brian Dinh, Ronald Markert, Mustafa Musleh, Sangeeta Agrawal
Boonshoft School of Medicine, Wright State University, USA
ABSTRACT

Background and Aims Pancreatitis presents with significant risk for morbidity and mortality acutely. The purpose of this study was to
evaluate demographics, comorbidity burden, and hospital characteristics and their effect on in-hospital mortality in patients with acute
pancreatitis. Methods Data was collected from The National Hospital Discharge Survey for patients admitted for acute pancreatitis from
2001-2010. Patients were separated into those who suffered in-hospital mortality and those that were discharged. Data was analyzed
regarding demographics, length of stay, comorbidity burden, mortality, principal payment, and hospital size. Statistical comparisons
were made using SPSS with chi-square and student T tests with a significance level of 0.05. Results 27,259 cases of acute pancreatitis
were identified, with 573 who suffered in-hospital mortality. The mortality group was significantly older and had a longer length of stay.
Patients with four or more comorbidities had a higher mortality rate (2.5%) compared to those with three or less (0.1%) (p<0.001).
Region displayed a difference in mortality, with the Midwest showing a lower rate (1.6%) compared to all other regions. Mortality was
lowest in small hospitals. Hospital ownership, however, did not show any significant differences in mortality. There was a difference
in mortality rate when comparing principal forms of payment (p<0.001), with Medicare and Medicaid patients having the highest
mortality rates. Conclusions Pancreatitis poses significant implications in morbidity and mortality in the acute setting. This study
shows that factors such as age, length of stay, comorbidity burden, principal source of payment, and regional demographics have an
impact on in-hospital mortality.

INTRODUCTION
Acute pancreatitis (AP) is an inflammatory process
of the pancreas that affects approximately 4.9 to 35 per
100,000 in the general population [1]. It is the leading
cause of gastrointestinal hospital admission [2]. A large
epidemiological study found that between 1988 and 2003,
the mortality from acute pancreatitis decreased from 12% to
2% with a higher incidence of mortality among black males
in their early 50’s [3]. Overall mortality of patients with acute
pancreatitis admitted to the hospital is estimated to be 5% to
10% varying from 3% in mild AP to 30% in severe AP [4, 5].
With significant risk of morbidity and mortality
associated with acute pancreatitis, multiple scoring
systems have been developed to assess its severity.
However, no single scoring system has been shown to be
superior to others in predicting in-hospital mortality [6,
7]. One of the early systems, Ranson’s criteria, focuses
on 11 factors with 5 assessed at the time of admission
and 6 assessed 48 hours into admission. For scores <3,
mortality was estimated to be 0% to 3%, scores ≥3 were
associated with a 11% to 15% mortality, and scores ≥6
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were associated with a 40% mortality. Although used
widely, a meta-analysis showed that Ranson’s criteria had
poor predictive value for acute pancreatitis severity [8].

Acute Physiology and Chronic Health Examination
(APACHE) II, another cumbersome scoring system, was
developed for use with critically ill patients, limiting
its applicability. The APACHE II score uses age and 12
physiologic measures and can be calculated each day.
Several studies have shown that an APACHE II score of less
than 8 has a mortality rate <4% while a score greater than
8 results in mortality between 11% to 18% [5, 9].
Bedside Index of Severity in Acute Pancreatitis (BISAP)
is a simpler calculation for determining early in-hospital
mortality of patients admitted for acute pancreatitis. A
BISAP score uses point assignments: 1 point for each of the
following - BUN >25 mg/dL, abnormal mental status with
Glasgow Coma Scale score <15, evidence of Systematic
Inflammatory Response Sydrome (SIRS), >60 years of age,
and imaging revealing pleural effusion. Patients with a
score of zero have less than 1% mortality while a score of
3 to 5 is associated with >15% mortality.

A recent validation study found that BISAP had similar
performance to APACHE II and Ranson’s criteria [10].
Moreover, BISAP compares favorably with newer scoring
systems for bedside AP assessment, such as the “harmless
acute pancreatitis score” and the “CT severity index” [10, 11].
In sum, AP severity scores are often unwieldy to measure
and may require recalculation at later times during the
hospital admission. In contrast, rather than focus on an
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AP score or index, other studies have investigated patient
demographics (e.g., age), clinical characteristics (e.g., BMI,
SIRS), various laboratory values, and radiological findings
to determine AP severity and risk of mortality [12, 13, 14].
We examined selected demographic factors,
comorbidities, and health care system characteristics that
might be predictors of morality in hospitalized patients
with acute pancreatitis.

METHODS

Study data was acquired from the National Hospital
Discharge Survey (NHDS), which is collected every year
through the National Center for Health Statistics.

The NHDS collects patient hospitalizations and
discharges from nonfederal hospitals across the United
States with average length of stay of <30 days and ≥6 beds.
Patient data in the NHDS is de-identified and made available
to the public via the Center for Disease Control, making it
exempt from an Institutional Review Board. The NHDS
database was searched using International Classification
of Diseases – Ninth Revision (ICD-9) diagnosis codes for
patients admitted to hospitals with acute pancreatitis
(ICD-9 code 577.0) from 2001-2010. For all patients
included in the study, the following data was obtained:
patient demographics (age, sex, race, marital status),
hospital length of stay (LOS), hospital size (by number of
beds), location/ownership (proprietary, government, or
church/nonprofit), type of admission (emergency/urgent/
elective), source of admission, comorbidity burden, and
mortality. This cohort was separated into two groups:
those who died during the hospitalization and those who
survived the hospitalization.

Means and standard deviations are reported for
continuous variables, and counts and percents for
categorical variables. The independent samples MannWhitney Test was used for comparisons involving the two
groups (mortality vs. no mortality) and a second variable
measured on a continuous scale. The chi square test was
used to compare the two groups on categorical variables.
Inferences for these univariate statistical tests were made
at the 0.05 level of significance with no corrections for
multiple comparisons. Multivariable logistic regression
was used to identify independent risk factors of mortality.
Data was first recorded in Excel, and analyses were conducted
using IBM SPSS Statistics 23.0 (IBM, Armonk, NY).

RESULTS

Table 1 shows the results for 27,259 patients admitted
for acute pancreatitis during the 2001-2010 periods. Of
this group, 573 (2.1%) suffered in-hospital mortality. The
mean age of patients who died was 64.5 years, which was
significantly higher than the survival group’s mean age of
51.8 years (p<0.001). Only two races had a large number
of patients: white (n=13,610) and African-American/
black (n=4984), and there was no difference in mortality
between these two groups (white 2.3% vs. A-A/black
2.2%; p=0.55).

Mean length of stay was nearly double (12.0 vs. 6.4
days, p<0.001) in the mortality group. Patients with four
or more comorbidities had a significantly higher mortality
rate (2.5%) compared to those with three or fewer
comorbidities (0.1%) (p<0.001).

Mortality was greater as hospital size increased,
with the largest hospitals having the highest mortality
rate (2.6%) and the smallest hospitals having the lowest
mortality rate (1.3%) (p<0.001). Mortality did not differ
by type of hospital ownership (p=0.49). Of the 10 principal
forms of payment, Medicare patients had significantly
higher mortality (3.6%) than patients with other insurers
– e.g., Medicaid (2.0%), HMO/PPO (1.4%), and self-pay
(1.0%) (p<0.001).
Mortality did not differ by type of admission (emergency
n=18,382; urgent n=4,287; and elective n=1,729). Elective
patients had a mortality rate of 2.8%, emergency 2.1%, and
urgent 1.8% (p=0.06). The hospitals in the Midwest had a
lower mortality rate (1.6%) compared to the Northeast
(2.5%), South (2.2%), and West (2.4%) (p=0.002).
Multivariable logistic regression (MLR) analysis was
used to identify independent predictors of mortality.
Predictors entered into the MLR equation were: age, sex,
race (white, African-American, other), comorbidities (3
or fewer, 4 or more), admission type (emergency, urgent,
elective), hospital length of stay, hospital region (Midwest,
other 3 regions), hospital size (99 or fewer beds, 100 or
more beds), hospital ownership (proprietary, government,
church/nonprofit), and principal payment (Medicare, 9
other insurers)

Table 2 shows the six independent risk factors.
The highest adjusted odds ratio (AOR) was four or
more comorbidities (AOR=15.22 [95% CI=4.87-47.54];
p<0.001), followed by hospital size of 100 beds or more
(AOR=1.42 [95% CI=1.04-1.95]; p=0.029), Midwest
region (AOR=1.31 [95% CI=1.05-1.64]; p=0.017), male
sex (AOR=1.26 [95% CI=1.05-1.52]; p=0.015), increasing
age (AOR=1.03 [95% CI=1.03-1.04]; p<0.001), and longer
hospital LOS (AOR=1.03 [95% CI=1.02-1.03]; p<0.001).

DISCUSSION

Using the National Hospital Discharge Survey (NHDS)
database, we identified six independent risk factors of
in-hospital mortality in acute pancreatitis patients: four
or more comorbidities, larger hospital size, treatment
outside the Midwest region, male sex, older age, and longer
hospital length of stay.
Our finding that AP patients with four or more
comorbidities are at increased risk of mortality is in
agreement with earlier studies [15, 16, 17]. Singh et al.
found a number of associations between various comorbid
conditions and mortality in patients with interstitial
pancreatitis [15]. Frey et al. reported that an increasing
number of chronic comorbidities were associated with
higher morality for acute pancreatitis [16]. These authors
also noted that older patients were more likely to die during
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Table 1. Characteristics evaluated for differences in mortality in acute pancreatitis.
Characteristic

Patients who did not die in the hospital

Number of patients
Age (years) (mean ± SD)
Sex
Male (percent)
Female (percent)
Race
Caucasian (percent)
African-Americans (percent)
Length of Stay (days) (mean ± SD)
Number of comorbidities
Three or less
Four or more
Region
Northeast
Midwest
South
West
Number of beds in hospital
6-99
100-199
200-299
300-499
>500
Hospital Ownership
Proprietary
Government
Nonprofit or church
Principal forms of payment
Workers compensation
Medicare
Medicaid
Other government
Blue cross/Blue shield
HMO/PPO
Other Private Insurance
Self-pay
No charge
Other
Not stated
Type of Admission
Emergency
Urgent
Elective
Not available

26686
64.52 ± 19.11

13195 (97.8%)
13491 (98%)

13292 (97.7%)
4875 (27.8%)
12.02 ± 16.28

4281 (99.9%)
22405 (97.5%)

4934 (97.5%)
7909 (98.4%)
10470 (97.8%)
3373 (97.6%)

3869 (98.7%)
6266 (97.9%)
6346 (98%)
7200 (97.6%)
3005 (97.4%)

2606 (98%)
2606 (97.6%0
21474 (97.9%)

15 (100%)
8436 (96.4%)
4177 (98%)
422 (98.4%)
2576 (98.9%)
4429 (98.6%)
2747 (98.8%)
2565 (99%)
204 (99.5%)
746 (99.2%)
369 (97.9%)

18000 (97.9%)
4210 (98.2%)
1681 (97.2%)
2794 (97.7%)

their hospitalization with AP. An epidemiological study
conducted in Japan found that patients older than 70 years
with severe comorbidities (>3 comorbid conditions) had
twice the risk of in-hospital mortality [17]. Also, Murata
et al. showed that cardiovascular and renal diseases are
factors that increase hospital length of stay and mortality
among AP patients [14]. With more comorbid conditions,
patients increase their likelihood of developing end organ
damage [18]. In our study, patients in the in-hospital
mortality group had a longer LOS. However, due to
multiple pre-existing comorbidities, those with longer LOS
may have had more complications. Others have found that
in-hospital mortality was higher in obese patients [19].

Patients who died in the
hospital
573
51.76 ± 19.09

303 (2.2%)
270 (2.0%)

318 (2.3%)
109 (2.2%)
6.37 ± 7.96

4 (0.1%)
569 (2.5%)

129 (2.5%)
131 (1.6%)
231 (2.2%)
82 (2.4%)

50 (1.3%)
134 (2.1%)
131 (2%)
177 (2.4%)
81 (2.6%)

52 (2%)
64 (2.4%)
457 (2.1%)

0 (0%)
316 (3.6%)
85 (%)
7 (1.6%)
29 (1.1%)
61 (1.4%)
33 (1.2%)
27 (1%)
1 (0.5%)
6 (0.8%)
8 (2.1%)

382 (2.1%)
98.2 (1.8%)
48 (2.8%)
66 (2.3%)

P value
<0.01

0.1

0.55

<0.001

<0.001
0.002

<0.001

0.49

<0.001

0.19

We found that in-hospital mortality varied by
geographical location. Midwestern states had a lower
mortality rate compared to Southern, Western, and
Northeastern states. These regional differences amongst
hospitals may be related to demographic (e.g., age),
clinical (e.g., obesity, number of comorbidities), and
socioeconomic (e.g., poverty) factors, population size, and
number of medical facilities per capita.

The scoring systems currently utilized to predict
mortality in patients with acute pancreatitis are often
inconvenient to calculate and do not facilitate efficient
triaging. Investigators have used serum markers and
radiological findings to predict AP severity and mortality.
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Table 2. Multivariable analysis of predictors of in-hospital mortality in acute pancreatitis.
Predictor
Age
Sex-male
Race
White
African-American
Comorbidities
Admission type
Elective
Emergency
Admission source
Emergency room
Hospital length of stay
Region- Midwest
Hospital size >100 beds
Hospital ownership
Government
Nonprofit/church
Principal payment
Medicare

Adjusted Odds Ratio
1.03
1.26

1.28
1.09
15.22

1.4
1.17

0.9
1.03
1.31
1.42

1.48
1.2

1.11

To our knowledge, no prior research has used the NHDS
database to examine demographic factors, comorbidities,
and health care system characteristics that may be
related to in-hospital mortality in patients with acute
pancreatitis.
While type of hospital ownership (proprietary,
government, or owned by a non-profit organization or
church) had similar rates of in-patient mortality, smaller
hospitals had lower mortality rates. Smaller hospitals
may manage primarily milder cases of acute pancreatitis
with patients having severe pancreatitis and related
complications transferred to large facilities more capable
of handling critically ill patients. Future investigations of
facility transfer related to pancreatitis may reveal why
mortality is lower in smaller hospitals.
Additionally, patients with Medicare as their primary
insurance had higher in-hospital mortality compared
to other forms of payment. However, the Medicare/
mortality relationship found with the univariate analysis
was not significant in the multivariable model. As
mentioned earlier, unfavorable demographic, clinical, and
socioeconomic factors may be more prevalent in Medicare
patients than with those having commercial and private
insurance coverage.

Mortality among elective and emergency admissions
was marginally higher than urgent admissions, but neither
hospitalization for elective or emergency reasons was
an independent predictor when urgent admission was
used as the reference standard. Emergency admissions
receive aggressive treatment and higher acuity of care
once admitted in comparison to those admitted electively.
Without access to individual patient data, we were not able
to examine clinical characteristics that might be related to
the type of admission.
Our study has several limitations. First, only non-federal
hospitals were included in the National Hospital Discharge

95% Confidence Interval
1.03-1.04
1.05-1.52

0.96-1.71
0.87-1.38
4.87-47.54

0.95-2.07
0.89-1.55

0.7-1.15
1.02-1.03
1.05-1.64
1.04-1.95

0.97-2.25
0.87-1.67

0.87-1.43

P value
<0.001
0.015

0.09
0.44
<0.001

0.09
0.26

0.4
<0.001
0.017
0.029

0.07
0.27

0.4

Survey database; thus, generalizability to Veterans Affairs
medical centers and other institutions should be done with
caution. Second, the NHDS database included readmissions
for acute pancreatitis; thus, the unit of analysis for the study
was events of AP and not independent patients with AP.
Finally, the NHDS data did not include lab values, treatment
choices, or longitudinal follow-up information; thus, the
impact of clinical characteristics could not be examined.

CONCLUSION

Our analysis of National Hospital Discharge Survey
data shows that demographic factors (sex and age),
clinical characteristics (comorbidities, length of stay),
and features of the health care system (geographic
location, hospital size) may be utilized as predictors
of in-patient mortality for those diagnosed with acute
pancreatitis. Future research may identify other
predictors of mortality that would improve the scoring
systems now used with acute pancreatitis patients.
As more research is conducted, a more accurate, less
cumbersome, and easily calculated scoring system may
be developed aiding in the reduction of in-hospital
mortality in patients with acute pancreatitis.
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